Decoding Pancreatic Metastases in Clear-Cell Kidney Cancer
Professor Franz Sellner's team reviewed evidence that isolated pancreatic metastases of clear-cell kidney cancer carry a distinct, less aggressive genetic profile, though the cases remain few.
Read the original paper
Pancreatic metastases from kidney cancer are rare and intriguing. Typically, when kidney cancer spreads, it affects multiple organs, but in these uncommon cases, it only affects the pancreas. Even more surprising is that these metastases often appear many years—sometimes nearly a decade—after the initial diagnosis of kidney cancer and the surprisingly favourable surgical and drug treatment results. This unusual pattern of cancer spread raises important questions about the genetic and biological factors that may explain such unique behavior.
Researchers, led by Professor Franz Sellner from the Kaiser Franz Josef Hospital, together with Professor Eva Compérat and Professor Martin Klimpfinger from the Medical University of Vienna, conducted a comprehensive review of existing research on isolated pancreatic metastases from clear-cell kidney cancer. This work provides an overview and analysis of the limited studies published so far on this rare form of metastasis. Their review was published in the International Journal of Molecular Sciences.
A key observation from the review is the frequent occurrence of changes in the PBRM1 gene, which have been linked to better outcomes for patients. Professor Sellner explained, “The results of our analysis suggest that genetic factors, like higher levels of PBRM1 mutations and fewer PAB1 mutations, may contribute to the less aggressive nature of pancreatic metastases when compared to other sites.” However, they stressed that these conclusions must be viewed cautiously due to the small number of cases available for study.
The review also examined the broader genetic and epigenetic factors (e.g. genetic profile, reduced DNA methylation in certain genes and altered microRNA activity) in RCC that might play a part in how cancers spreads and grows in the pancreas. As the authors point out, the isPMRCC showed an independent genetic profile characterized by a low frequency of copy number variants associated with aggressiveness like 9p, 14q and 4q loss, and a low genetic instability index. Furthermore, the pancreatic metastases of clear cell renal carcinoma do not belong to an inflammatory but to angiogenetic subtype. This behaviour, in turn, confirms the limited clinical data of a good response to antiangiogenic therapy in the absence of response to IT. This type of tumour is also developing into personalized therapies, where doctors tailor therapies based on an individual’s genetic/epigenetic makeup, are important in managing these unique pancreatic metastases.
Their review also supports the “seed and soil” idea, which proposes that some cancers tend to spread to specific organs because of favorable conditions in those tissues. In this case, the pancreas may offer an environment where genetically stable cancer cells can grow more easily. “This theory provides insight into why the pancreas might be more likely to attract these metastases, but more research is needed to fully understand the underlying reasons,” Professor Sellner commented.
Overall, the review by Professor Sellner, Professor Compérat, and Professor Klimpfinger offers valuable insights into the genetic and biological traits of isolated pancreatic metastases from clear-cell kidney cancer. The researchers emphasize that these findings should be interpreted with care, as the number of cases is still small and more research is necessary. Their work paves the way for future studies that could lead to better, more personalized treatments for this rare form of cancer, and may be one day help us therapeutically reduce the metastatic potential of tumours.
About the researchers
Journal reference
Sellner, F., Compérat, E., & Klimpfinger, M. “Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.” Int. J. Mol. Sci. 2023, 24, 16292. DOI: https://doi.org/10.3390/ijms242216292





